#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=[0013] Embodiments of the invention relate to a device and method that employ photo-induced charge separation and an electrical sensor detecting the charge separation.
1-1	0-1	[	_	_	
1-2	1-5	0013	_	_	
1-3	5-6	]	_	_	
1-4	7-18	Embodiments	_	_	
1-5	19-21	of	_	_	
1-6	22-25	the	_	_	
1-7	26-35	invention	_	_	
1-8	36-42	relate	_	_	
1-9	43-45	to	_	_	
1-10	46-47	a	_	_	
1-11	48-54	device	_	_	
1-12	55-58	and	_	_	
1-13	59-65	method	_	_	
1-14	66-70	that	_	_	
1-15	71-77	employ	_	_	
1-16	78-91	photo-induced	_	_	
1-17	92-98	charge	_	_	
1-18	99-109	separation	_	_	
1-19	110-113	and	_	_	
1-20	114-116	an	_	_	
1-21	117-127	electrical	_	_	
1-22	128-134	sensor	_	_	
1-23	135-144	detecting	_	_	
1-24	145-148	the	_	_	
1-25	149-155	charge	_	_	
1-26	156-166	separation	_	_	
1-27	166-167	.	_	_	

#Text=In the embodiments, the photo-induced charge separation is a reflection of specific chemical and/or biological interactions and is detected by the electrical sensors, which can be part of an integrated on-chip device for performing chemical analysis and medical diagnostics.
2-1	168-170	In	_	_	
2-2	171-174	the	_	_	
2-3	175-186	embodiments	_	_	
2-4	186-187	,	_	_	
2-5	188-191	the	_	_	
2-6	192-205	photo-induced	_	_	
2-7	206-212	charge	_	_	
2-8	213-223	separation	_	_	
2-9	224-226	is	_	_	
2-10	227-228	a	_	_	
2-11	229-239	reflection	_	_	
2-12	240-242	of	_	_	
2-13	243-251	specific	_	_	
2-14	252-260	chemical	_	_	
2-15	261-264	and	_	_	
2-16	264-265	/	_	_	
2-17	265-267	or	_	_	
2-18	268-278	biological	_	_	
2-19	279-291	interactions	_	_	
2-20	292-295	and	_	_	
2-21	296-298	is	_	_	
2-22	299-307	detected	_	_	
2-23	308-310	by	_	_	
2-24	311-314	the	_	_	
2-25	315-325	electrical	_	_	
2-26	326-333	sensors	_	_	
2-27	333-334	,	_	_	
2-28	335-340	which	_	_	
2-29	341-344	can	_	_	
2-30	345-347	be	_	_	
2-31	348-352	part	_	_	
2-32	353-355	of	_	_	
2-33	356-358	an	_	_	
2-34	359-369	integrated	_	_	
2-35	370-377	on-chip	_	_	
2-36	378-384	device	_	_	
2-37	385-388	for	_	_	
2-38	389-399	performing	_	_	
2-39	400-408	chemical	_	_	
2-40	409-417	analysis	_	_	
2-41	418-421	and	_	_	
2-42	422-429	medical	_	_	
2-43	430-441	diagnostics	_	_	
2-44	441-442	.	_	_	

#Text=In specific embodiments, the electrical sensor is a field effect transistor that detects photo-induced charge separations occur in materials involved in specific chemical or biological interactions.
#Text=[0014] The embodiments of the invention further relate to a device and method where an array of electrical sensors and corresponding molecular complexes are contained in a single substrate.
3-1	443-445	In	_	_	
3-2	446-454	specific	_	_	
3-3	455-466	embodiments	_	_	
3-4	466-467	,	_	_	
3-5	468-471	the	_	_	
3-6	472-482	electrical	_	_	
3-7	483-489	sensor	_	_	
3-8	490-492	is	_	_	
3-9	493-494	a	_	_	
3-10	495-500	field	_	_	
3-11	501-507	effect	_	_	
3-12	508-518	transistor	_	_	
3-13	519-523	that	_	_	
3-14	524-531	detects	_	_	
3-15	532-545	photo-induced	_	_	
3-16	546-552	charge	_	_	
3-17	553-564	separations	_	_	
3-18	565-570	occur	_	_	
3-19	571-573	in	_	_	
3-20	574-583	materials	_	_	
3-21	584-592	involved	_	_	
3-22	593-595	in	_	_	
3-23	596-604	specific	_	_	
3-24	605-613	chemical	_	_	
3-25	614-616	or	_	_	
3-26	617-627	biological	_	_	
3-27	628-640	interactions	_	_	
3-28	640-641	.	_	_	
3-29	642-643	[	_	_	
3-30	643-647	0014	_	_	
3-31	647-648	]	_	_	
3-32	649-652	The	_	_	
3-33	653-664	embodiments	_	_	
3-34	665-667	of	_	_	
3-35	668-671	the	_	_	
3-36	672-681	invention	_	_	
3-37	682-689	further	_	_	
3-38	690-696	relate	_	_	
3-39	697-699	to	_	_	
3-40	700-701	a	_	_	
3-41	702-708	device	_	_	
3-42	709-712	and	_	_	
3-43	713-719	method	_	_	
3-44	720-725	where	_	_	
3-45	726-728	an	_	_	
3-46	729-734	array	_	_	
3-47	735-737	of	_	_	
3-48	738-748	electrical	_	_	
3-49	749-756	sensors	_	_	
3-50	757-760	and	_	_	
3-51	761-774	corresponding	_	_	
3-52	775-784	molecular	_	_	
3-53	785-794	complexes	_	_	
3-54	795-798	are	_	_	
3-55	799-808	contained	_	_	
3-56	809-811	in	_	_	
3-57	812-813	a	_	_	
3-58	814-820	single	_	_	
3-59	821-830	substrate	_	_	
3-60	830-831	.	_	_	

#Text=Signals from the electrical sensor are detected and collected by circuitries on the substrate or in a separate device.
4-1	832-839	Signals	_	_	
4-2	840-844	from	_	_	
4-3	845-848	the	_	_	
4-4	849-859	electrical	_	_	
4-5	860-866	sensor	_	_	
4-6	867-870	are	_	_	
4-7	871-879	detected	_	_	
4-8	880-883	and	_	_	
4-9	884-893	collected	_	_	
4-10	894-896	by	_	_	
4-11	897-908	circuitries	_	_	
4-12	909-911	on	_	_	
4-13	912-915	the	_	_	
4-14	916-925	substrate	_	_	
4-15	926-928	or	_	_	
4-16	929-931	in	_	_	
4-17	932-933	a	_	_	
4-18	934-942	separate	_	_	
4-19	943-949	device	_	_	
4-20	949-950	.	_	_	

#Text=One application of the electrical sensor array of the invention is their use in a protein or DNA array for simultaneous multiple protein or DNA analysis.
5-1	951-954	One	_	_	
5-2	955-966	application	_	_	
5-3	967-969	of	_	_	
5-4	970-973	the	_	_	
5-5	974-984	electrical	_	_	
5-6	985-991	sensor	_	_	
5-7	992-997	array	_	_	
5-8	998-1000	of	_	_	
5-9	1001-1004	the	_	_	
5-10	1005-1014	invention	_	_	
5-11	1015-1017	is	_	_	
5-12	1018-1023	their	_	_	
5-13	1024-1027	use	_	_	
5-14	1028-1030	in	_	_	
5-15	1031-1032	a	_	_	
5-16	1033-1040	protein	_	_	
5-17	1041-1043	or	_	_	
5-18	1044-1047	DNA	_	_	
5-19	1048-1053	array	_	_	
5-20	1054-1057	for	_	_	
5-21	1058-1070	simultaneous	_	_	
5-22	1071-1079	multiple	_	_	
5-23	1080-1087	protein	_	_	
5-24	1088-1090	or	_	_	
5-25	1091-1094	DNA	_	_	
5-26	1095-1103	analysis	_	_	
5-27	1103-1104	.	_	_	

#Text=The substrate of the embodiments of the invention may be part of an integrated device that also serves as a microarray or macroarray, an integrated circuit, a microfluidic device, a MEMS, or a combination.
6-1	1105-1108	The	_	_	
6-2	1109-1118	substrate	_	_	
6-3	1119-1121	of	_	_	
6-4	1122-1125	the	_	_	
6-5	1126-1137	embodiments	_	_	
6-6	1138-1140	of	_	_	
6-7	1141-1144	the	_	_	
6-8	1145-1154	invention	_	_	
6-9	1155-1158	may	_	_	
6-10	1159-1161	be	_	_	
6-11	1162-1166	part	_	_	
6-12	1167-1169	of	_	_	
6-13	1170-1172	an	_	_	
6-14	1173-1183	integrated	_	_	
6-15	1184-1190	device	_	_	
6-16	1191-1195	that	_	_	
6-17	1196-1200	also	_	_	
6-18	1201-1207	serves	_	_	
6-19	1208-1210	as	_	_	
6-20	1211-1212	a	_	_	
6-21	1213-1223	microarray	_	_	
6-22	1224-1226	or	_	_	
6-23	1227-1237	macroarray	_	_	
6-24	1237-1238	,	_	_	
6-25	1239-1241	an	_	_	
6-26	1242-1252	integrated	_	_	
6-27	1253-1260	circuit	_	_	
6-28	1260-1261	,	_	_	
6-29	1262-1263	a	_	_	
6-30	1264-1276	microfluidic	_	_	
6-31	1277-1283	device	_	_	
6-32	1283-1284	,	_	_	
6-33	1285-1286	a	_	_	
6-34	1287-1291	MEMS	_	_	
6-35	1291-1292	,	_	_	
6-36	1293-1295	or	_	_	
6-37	1296-1297	a	_	_	
6-38	1298-1309	combination	_	_	
6-39	1309-1310	.	_	_	

#Text=Therefore, samples contained or processed by the device may be also analyzed by the integrated device and the signals processed for analysis.
#Text=[0015] A biological sample often contains many thousands or even more types of biomolecules and clinical diagnosis needs to measure multiple analytes for disease confirmation.
7-1	1311-1320	Therefore	_	_	
7-2	1320-1321	,	_	_	
7-3	1322-1329	samples	_	_	
7-4	1330-1339	contained	_	_	
7-5	1340-1342	or	_	_	
7-6	1343-1352	processed	_	_	
7-7	1353-1355	by	_	_	
7-8	1356-1359	the	_	_	
7-9	1360-1366	device	_	_	
7-10	1367-1370	may	_	_	
7-11	1371-1373	be	_	_	
7-12	1374-1378	also	_	_	
7-13	1379-1387	analyzed	_	_	
7-14	1388-1390	by	_	_	
7-15	1391-1394	the	_	_	
7-16	1395-1405	integrated	_	_	
7-17	1406-1412	device	_	_	
7-18	1413-1416	and	_	_	
7-19	1417-1420	the	_	_	
7-20	1421-1428	signals	_	_	
7-21	1429-1438	processed	_	_	
7-22	1439-1442	for	_	_	
7-23	1443-1451	analysis	_	_	
7-24	1451-1452	.	_	_	
7-25	1453-1454	[	_	_	
7-26	1454-1458	0015	_	_	
7-27	1458-1459	]	_	_	
7-28	1460-1461	A	_	_	
7-29	1462-1472	biological	_	_	
7-30	1473-1479	sample	_	_	
7-31	1480-1485	often	_	_	
7-32	1486-1494	contains	_	_	
7-33	1495-1499	many	_	_	
7-34	1500-1509	thousands	_	_	
7-35	1510-1512	or	_	_	
7-36	1513-1517	even	_	_	
7-37	1518-1522	more	_	_	
7-38	1523-1528	types	_	_	
7-39	1529-1531	of	_	_	
7-40	1532-1544	biomolecules	_	_	
7-41	1545-1548	and	_	_	
7-42	1549-1557	clinical	_	_	
7-43	1558-1567	diagnosis	_	_	
7-44	1568-1573	needs	_	_	
7-45	1574-1576	to	_	_	
7-46	1577-1584	measure	_	_	
7-47	1585-1593	multiple	_	_	
7-48	1594-1602	analytes	_	_	
7-49	1603-1606	for	_	_	
7-50	1607-1614	disease	_	_	
7-51	1615-1627	confirmation	_	_	
7-52	1627-1628	.	_	_	

#Text=Currently, each analyte is measured separately, which requires multiple samples from a patient.
8-1	1629-1638	Currently	*[1]	10-21[2_1]	
8-2	1638-1639	,	*[1]	_	
8-3	1640-1644	each	*[1]	_	
8-4	1645-1652	analyte	*[1]	_	
8-5	1653-1655	is	*[1]	_	
8-6	1656-1664	measured	*[1]	_	
8-7	1665-1675	separately	*[1]	_	
8-8	1675-1676	,	*[1]	_	
8-9	1677-1682	which	*[1]	_	
8-10	1683-1691	requires	*[1]	_	
8-11	1692-1700	multiple	*[1]	_	
8-12	1701-1708	samples	*[1]	_	
8-13	1709-1713	from	*[1]	_	
8-14	1714-1715	a	*[1]	_	
8-15	1716-1723	patient	*[1]	_	
8-16	1723-1724	.	*[1]	_	

#Text=The procedure is time consuming and labor intensive.
9-1	1725-1728	The	_	_	
9-2	1729-1738	procedure	_	_	
9-3	1739-1741	is	_	_	
9-4	1742-1746	time	_	_	
9-5	1747-1756	consuming	_	_	
9-6	1757-1760	and	_	_	
9-7	1761-1766	labor	_	_	
9-8	1767-1776	intensive	_	_	
9-9	1776-1777	.	_	_	

#Text=Multiplex assays, in which multiple analytes can be measured at the same time, have been developed to solve this problem.
10-1	1778-1787	Multiplex	_	_	
10-2	1788-1794	assays	_	_	
10-3	1794-1795	,	_	_	
10-4	1796-1798	in	_	_	
10-5	1799-1804	which	_	_	
10-6	1805-1813	multiple	_	_	
10-7	1814-1822	analytes	_	_	
10-8	1823-1826	can	_	_	
10-9	1827-1829	be	_	_	
10-10	1830-1838	measured	_	_	
10-11	1839-1841	at	_	_	
10-12	1842-1845	the	_	_	
10-13	1846-1850	same	_	_	
10-14	1851-1855	time	_	_	
10-15	1855-1856	,	_	_	
10-16	1857-1861	have	_	_	
10-17	1862-1866	been	_	_	
10-18	1867-1876	developed	_	_	
10-19	1877-1879	to	_	_	
10-20	1880-1885	solve	_	_	
10-21	1886-1890	this	*[2]	_	
10-22	1891-1898	problem	*[2]	_	
10-23	1898-1899	.	_	_	

#Text=However, in conventional multiplex assays, the detection of different types of labels, such as nanoparticles, are not effective due to signal strength and sensitivity.
#Text=[0016] Current photo detection devices are usually large in size and are difficult to be included in an integrated device.
11-1	1900-1907	However	_	_	
11-2	1907-1908	,	_	_	
11-3	1909-1911	in	_	_	
11-4	1912-1924	conventional	_	_	
11-5	1925-1934	multiplex	_	_	
11-6	1935-1941	assays	_	_	
11-7	1941-1942	,	_	_	
11-8	1943-1946	the	_	_	
11-9	1947-1956	detection	_	_	
11-10	1957-1959	of	_	_	
11-11	1960-1969	different	_	_	
11-12	1970-1975	types	_	_	
11-13	1976-1978	of	_	_	
11-14	1979-1985	labels	_	_	
11-15	1985-1986	,	_	_	
11-16	1987-1991	such	_	_	
11-17	1992-1994	as	_	_	
11-18	1995-2008	nanoparticles	_	_	
11-19	2008-2009	,	_	_	
11-20	2010-2013	are	_	_	
11-21	2014-2017	not	_	_	
11-22	2018-2027	effective	_	_	
11-23	2028-2031	due	_	_	
11-24	2032-2034	to	_	_	
11-25	2035-2041	signal	_	_	
11-26	2042-2050	strength	_	_	
11-27	2051-2054	and	_	_	
11-28	2055-2066	sensitivity	_	_	
11-29	2066-2067	.	_	_	
11-30	2068-2069	[	_	_	
11-31	2069-2073	0016	_	_	
11-32	2073-2074	]	_	_	
11-33	2075-2082	Current	_	_	
11-34	2083-2088	photo	_	_	
11-35	2089-2098	detection	_	_	
11-36	2099-2106	devices	_	_	
11-37	2107-2110	are	_	_	
11-38	2111-2118	usually	_	_	
11-39	2119-2124	large	_	_	
11-40	2125-2127	in	_	_	
11-41	2128-2132	size	_	_	
11-42	2133-2136	and	_	_	
11-43	2137-2140	are	_	_	
11-44	2141-2150	difficult	_	_	
11-45	2151-2153	to	_	_	
11-46	2154-2156	be	_	_	
11-47	2157-2165	included	_	_	
11-48	2166-2168	in	_	_	
11-49	2169-2171	an	_	_	
11-50	2172-2182	integrated	_	_	
11-51	2183-2189	device	_	_	
11-52	2189-2190	.	_	_	

#Text=On the other hand, field effect transistors have the advantage of being small in size and easily integratable into a single device.
12-1	2191-2193	On	_	_	
12-2	2194-2197	the	_	_	
12-3	2198-2203	other	_	_	
12-4	2204-2208	hand	_	_	
12-5	2208-2209	,	_	_	
12-6	2210-2215	field	_	_	
12-7	2216-2222	effect	_	_	
12-8	2223-2234	transistors	_	_	
12-9	2235-2239	have	_	_	
12-10	2240-2243	the	_	_	
12-11	2244-2253	advantage	_	_	
12-12	2254-2256	of	_	_	
12-13	2257-2262	being	_	_	
12-14	2263-2268	small	_	_	
12-15	2269-2271	in	_	_	
12-16	2272-2276	size	_	_	
12-17	2277-2280	and	_	_	
12-18	2281-2287	easily	_	_	
12-19	2288-2300	integratable	_	_	
12-20	2301-2305	into	_	_	
12-21	2306-2307	a	_	_	
12-22	2308-2314	single	_	_	
12-23	2315-2321	device	_	_	
12-24	2321-2322	.	_	_	

#Text=But, due to problems related to signal intensity and sensitivity, FETs have drawbacks in serving as electrical sensors.
13-1	2323-2326	But	_	_	
13-2	2326-2327	,	_	_	
13-3	2328-2331	due	_	_	
13-4	2332-2334	to	_	_	
13-5	2335-2343	problems	_	_	
13-6	2344-2351	related	_	_	
13-7	2352-2354	to	_	_	
13-8	2355-2361	signal	_	_	
13-9	2362-2371	intensity	_	_	
13-10	2372-2375	and	_	_	
13-11	2376-2387	sensitivity	_	_	
13-12	2387-2388	,	_	_	
13-13	2389-2393	FETs	_	_	
13-14	2394-2398	have	_	_	
13-15	2399-2408	drawbacks	_	_	
13-16	2409-2411	in	_	_	
13-17	2412-2419	serving	_	_	
13-18	2420-2422	as	_	_	
13-19	2423-2433	electrical	_	_	
13-20	2434-2441	sensors	_	_	
13-21	2441-2442	.	_	_	

#Text=Embodiments of the present invention combine the principles of photo-induced charge separation and field effect transistors as electrical sensors and achieve detection of analytes, especially bioanalytes, that is more specific and sensitive.
#Text=[0017] In the embodiments of the invention, analytes that can be detected include antigens of all types, such as proteins, polysaccharides, and small molecules coupled to a protein.
14-1	2443-2454	Embodiments	_	_	
14-2	2455-2457	of	_	_	
14-3	2458-2461	the	_	_	
14-4	2462-2469	present	_	_	
14-5	2470-2479	invention	_	_	
14-6	2480-2487	combine	_	_	
14-7	2488-2491	the	_	_	
14-8	2492-2502	principles	_	_	
14-9	2503-2505	of	_	_	
14-10	2506-2519	photo-induced	_	_	
14-11	2520-2526	charge	_	_	
14-12	2527-2537	separation	_	_	
14-13	2538-2541	and	_	_	
14-14	2542-2547	field	_	_	
14-15	2548-2554	effect	_	_	
14-16	2555-2566	transistors	_	_	
14-17	2567-2569	as	_	_	
14-18	2570-2580	electrical	_	_	
14-19	2581-2588	sensors	_	_	
14-20	2589-2592	and	_	_	
14-21	2593-2600	achieve	_	_	
14-22	2601-2610	detection	_	_	
14-23	2611-2613	of	_	_	
14-24	2614-2622	analytes	_	_	
14-25	2622-2623	,	_	_	
14-26	2624-2634	especially	_	_	
14-27	2635-2646	bioanalytes	_	_	
14-28	2646-2647	,	_	_	
14-29	2648-2652	that	_	_	
14-30	2653-2655	is	_	_	
14-31	2656-2660	more	_	_	
14-32	2661-2669	specific	_	_	
14-33	2670-2673	and	_	_	
14-34	2674-2683	sensitive	_	_	
14-35	2683-2684	.	_	_	
14-36	2685-2686	[	_	_	
14-37	2686-2690	0017	_	_	
14-38	2690-2691	]	_	_	
14-39	2692-2694	In	_	_	
14-40	2695-2698	the	_	_	
14-41	2699-2710	embodiments	_	_	
14-42	2711-2713	of	_	_	
14-43	2714-2717	the	_	_	
14-44	2718-2727	invention	_	_	
14-45	2727-2728	,	_	_	
14-46	2729-2737	analytes	_	_	
14-47	2738-2742	that	_	_	
14-48	2743-2746	can	_	_	
14-49	2747-2749	be	_	_	
14-50	2750-2758	detected	_	_	
14-51	2759-2766	include	_	_	
14-52	2767-2775	antigens	_	_	
14-53	2776-2778	of	_	_	
14-54	2779-2782	all	_	_	
14-55	2783-2788	types	_	_	
14-56	2788-2789	,	_	_	
14-57	2790-2794	such	_	_	
14-58	2795-2797	as	_	_	
14-59	2798-2806	proteins	_	_	
14-60	2806-2807	,	_	_	
14-61	2808-2823	polysaccharides	_	_	
14-62	2823-2824	,	_	_	
14-63	2825-2828	and	_	_	
14-64	2829-2834	small	_	_	
14-65	2835-2844	molecules	_	_	
14-66	2845-2852	coupled	_	_	
14-67	2853-2855	to	_	_	
14-68	2856-2857	a	_	_	
14-69	2858-2865	protein	_	_	
14-70	2865-2866	.	_	_	

#Text=The specific bindings between antigens and their corresponding antibodies form the basis of immunoassays.
15-1	2867-2870	The	_	_	
15-2	2871-2879	specific	_	_	
15-3	2880-2888	bindings	_	_	
15-4	2889-2896	between	_	_	
15-5	2897-2905	antigens	_	_	
15-6	2906-2909	and	_	_	
15-7	2910-2915	their	_	_	
15-8	2916-2929	corresponding	_	_	
15-9	2930-2940	antibodies	_	_	
15-10	2941-2945	form	_	_	
15-11	2946-2949	the	_	_	
15-12	2950-2955	basis	_	_	
15-13	2956-2958	of	_	_	
15-14	2959-2971	immunoassays	_	_	
15-15	2971-2972	.	_	_	

#Text=Antibodies suitable for the embodiments of the invention include monoclonal antibodies, polyclonal antibodies, recombinant antibodies, random peptides and aptamers.
16-1	2973-2983	Antibodies	_	_	
16-2	2984-2992	suitable	_	_	
16-3	2993-2996	for	_	_	
16-4	2997-3000	the	_	_	
16-5	3001-3012	embodiments	_	_	
16-6	3013-3015	of	_	_	
16-7	3016-3019	the	_	_	
16-8	3020-3029	invention	_	_	
16-9	3030-3037	include	_	_	
16-10	3038-3048	monoclonal	_	_	
16-11	3049-3059	antibodies	_	_	
16-12	3059-3060	,	_	_	
16-13	3061-3071	polyclonal	_	_	
16-14	3072-3082	antibodies	_	_	
16-15	3082-3083	,	_	_	
16-16	3084-3095	recombinant	_	_	
16-17	3096-3106	antibodies	_	_	
16-18	3106-3107	,	_	_	
16-19	3108-3114	random	_	_	
16-20	3115-3123	peptides	_	_	
16-21	3124-3127	and	_	_	
16-22	3128-3136	aptamers	_	_	
16-23	3136-3137	.	_	_	

#Text=Immunoassays suitable for the embodiments of the invention include solid-phase immunoassays based the sandwich principle and the competing principle.
17-1	3138-3150	Immunoassays	_	_	
17-2	3151-3159	suitable	_	_	
17-3	3160-3163	for	_	_	
17-4	3164-3167	the	_	_	
17-5	3168-3179	embodiments	_	_	
17-6	3180-3182	of	_	_	
17-7	3183-3186	the	_	_	
17-8	3187-3196	invention	_	_	
17-9	3197-3204	include	_	_	
17-10	3205-3216	solid-phase	_	_	
17-11	3217-3229	immunoassays	_	_	
17-12	3230-3235	based	_	_	
17-13	3236-3239	the	_	_	
17-14	3240-3248	sandwich	_	_	
17-15	3249-3258	principle	_	_	
17-16	3259-3262	and	_	_	
17-17	3263-3266	the	_	_	
17-18	3267-3276	competing	_	_	
17-19	3277-3286	principle	_	_	
17-20	3286-3287	.	_	_	

#Text=Also included are specific types of immunoassays such as enzyme-linked immunosorbent assay (ELISA) and electrochemiluminescence (ECL).
18-1	3288-3292	Also	_	_	
18-2	3293-3301	included	_	_	
18-3	3302-3305	are	_	_	
18-4	3306-3314	specific	_	_	
18-5	3315-3320	types	_	_	
18-6	3321-3323	of	_	_	
18-7	3324-3336	immunoassays	_	_	
18-8	3337-3341	such	_	_	
18-9	3342-3344	as	_	_	
18-10	3345-3358	enzyme-linked	_	_	
18-11	3359-3372	immunosorbent	_	_	
18-12	3373-3378	assay	_	_	
18-13	3379-3380	(	_	_	
18-14	3380-3385	ELISA	_	_	
18-15	3385-3386	)	_	_	
18-16	3387-3390	and	_	_	
18-17	3391-3415	electrochemiluminescence	_	_	
18-18	3416-3417	(	_	_	
18-19	3417-3420	ECL	_	_	
18-20	3420-3421	)	_	_	
18-21	3421-3422	.	_	_	
